Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Cerchietti Research Lab
Explore this Website
Home
Research
Toggle Research menu options
Projects
Lab Team
Publications
News
Weill Cornell Medicine
Care
Discover
Teach
Home
Research
Lab Team
Publications
News
Home
Publications
Publications
Found 101 results
Author
Title
Type
Year
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
G
Ghram M
,
Morris G
,
Culjkovic-Kraljacic B
,
Mars J-C
,
Gendron P
,
Skrabanek L
,
Revuelta MVictoria
,
Cerchietti L
,
Guzman ML
,
Borden KLB
. 2023.
The eukaryotic translation initiation factor eIF4E reprograms alternative splicing.
.
EMBO J. 42(7):e110496.
Goldstein RL
,
Yang SNing
,
Taldone T
,
Chang B
,
Gerecitano J
,
Elenitoba-Johnson K
,
Shaknovich R
,
Tam W
,
Leonard JP
,
Chiosis G
et al.
. 2015.
Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphoma.
.
J Clin Invest. 125(12):4559-71.
Gomari DP
,
Schweickart A
,
Cerchietti L
,
Paietta E
,
Fernandez H
,
Al-Amin H
,
Suhre K
,
Krumsiek J
. 2022.
Variational autoencoders learn transferrable representations of metabolomics data.
.
Commun Biol. 5(1):645.
H
Ha K
,
Fiskus W
,
Choi DSoon
,
Bhaskara S
,
Cerchietti L
,
Devaraj SGT
,
Shah B
,
Sharma S
,
Chang JC
,
Melnick AM
et al.
. 2014.
Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells.
.
Oncotarget. 5(14):5637-50.
Hatzi K
,
Jiang Y
,
Huang C
,
Garrett-Bakelman F
,
Gearhart MD
,
Giannopoulou EG
,
Zumbo P
,
Kirouac K
,
Bhaskara S
,
Polo JM
et al.
. 2013.
A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters.
.
Cell Rep. 4(3):578-88.
Hurtz C
,
Hatzi K
,
Cerchietti L
,
Braig M
,
Park E
,
Kim Y-mi
,
Herzog S
,
Ramezani-Rad P
,
Jumaa H
,
Müller MC
et al.
. 2011.
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia.
.
J Exp Med. 208(11):2163-74.
I
Irmady K
,
Jackman KA
,
Padow VA
,
Shahani N
,
Martin LAndres
,
Cerchietti L
,
Unsicker K
,
Iadecola C
,
Hempstead BL
. 2014.
Mir-592 regulates the induction and cell death-promoting activity of p75NTR in neuronal ischemic injury.
.
J Neurosci. 34(9):3419-28.
Izzo F
,
Mercogliano F
,
Venturutti L
,
Tkach M
,
Inurrigarro G
,
Schillaci R
,
Cerchietti L
,
Elizalde PV
,
Proietti CJ
. 2014.
Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
.
Breast Cancer Res. 16(6):491.
K
Kotlov N
,
Bagaev A
,
Revuelta MV
,
Phillip JM
,
Cacciapuoti MTeresa
,
Antysheva Z
,
Svekolkin V
,
Tikhonova E
,
Miheecheva N
,
Kuzkina N
et al.
. 2021.
Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures.
.
Cancer Discov.
L
Larrayoz M
,
Garcia-Barchino MJ
,
Celay J
,
Etxebeste A
,
Jimenez M
,
Perez C
,
Ordoñez R
,
Cobaleda C
,
Botta C
,
Fresquet V
et al.
. 2023.
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.
.
Nat Med. 29(3):632-645.
Li M
,
Teater MR
,
Hong JYoung
,
Park NR
,
Duy C
,
Shen H
,
Wang L
,
Chen Z
,
Cerchietti L
,
Davidson SM
et al.
. 2022.
Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival.
.
Blood Cancer Discov. 3(1):50-65.
Li M
,
Chiang Y-L
,
Lyssiotis CA
,
Teater MR
,
Hong JYoung
,
Shen H
,
Wang L
,
Hu J
,
Jing H
,
Chen Z
et al.
. 2019.
Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis.
.
Cancer Cell. 35(6):916-931.e9.
M
Martin P
,
Bartlett NL
,
Chavez JC
,
Reagan JL
,
Smith SM
,
LaCasce AS
,
Jones J
,
Drew J
,
Wu C
,
Mulvey E
et al.
. 2022.
Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL.
.
Blood. 139(8):1147-1159.
Marullo R
,
Rutherford SC
,
Leonard JP
,
Cerchietti L
. 2016.
Therapeutic implication of concomitant chromosomal aberrations in patients with aggressive B-cell lymphomas.
.
Cell Cycle. 15(17):2241-7.
Marullo R
,
Castro M
,
Yomtoubian S
,
M Calvo-Vidal N
,
Revuelta MVictoria
,
Krumsiek J
,
Cho A
,
Morgado PCresta
,
Yang SN
,
Medina V
et al.
. 2021.
The metabolic adaptation evoked by arginine enhances the effect of radiation in brain metastases.
.
Sci Adv. 7(45):eabg1964.
McIntyre ABR
,
Gokhale NS
,
Cerchietti L
,
Jaffrey SR
,
Horner SM
,
Mason CE
. 2020.
Limits in the detection of mA changes using MeRIP/mA-seq.
.
Sci Rep. 10(1):6590.
Moulick K
,
Ahn JH
,
Zong H
,
Rodina A
,
Cerchietti L
,
DaGama EMGomes
,
Caldas-Lopes E
,
Beebe K
,
Perna F
,
Hatzi K
et al.
. 2011.
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.
.
Nat Chem Biol. 7(11):818-26.
N
Nahar R
,
Ramezani-Rad P
,
Mossner M
,
Duy C
,
Cerchietti L
,
Geng H
,
Dovat S
,
Jumaa H
,
B Ye H
,
Melnick A
et al.
. 2011.
Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC.
.
Blood. 118(15):4174-8.
Napoli S
,
Cascione L
,
Rinaldi A
,
Spriano F
,
Guidetti F
,
Zhang F
,
Cacciapuoti MTeresa
,
Mensah AAdjeiwaa
,
Sartori G
,
Munz N
et al.
. 2021.
Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B cell lymphoma.
.
Haematologica.
Navigante AH
,
Cerchietti LCA
,
Castro MA
,
Lutteral MA
,
Cabalar ME
. 2006.
Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer.
.
J Pain Symptom Manage. 31(1):38-47.
Navigante AH
,
Castro MA
,
Cerchietti LC
. 2010.
Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated.
.
J Pain Symptom Manage. 39(5):820-30.
Navigante AH
,
Cerchietti LCA
,
Costantini P
,
Salgado H
,
Castro MA
,
Lutteral MA
,
Cabalar ME
. 2002.
Conventional chest radiography in the initial assessment of adult cancer patients with fever and neutropenia.
.
Cancer Control. 9(4):346-51.
Nayar U
,
Lu P
,
Goldstein RL
,
Vider J
,
Ballon G
,
Rodina A
,
Taldone T
,
Erdjument-Bromage H
,
Chomet M
,
Blasberg R
et al.
. 2013.
Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies.
.
Blood. 122(16):2837-47.
Nielsen THolm
,
Diaz Z
,
Christodoulopoulos R
,
Charbonneau F
,
Qureshi S
,
Rousseau C
,
Benlimame N
,
Camlioglu E
,
Constantin AMarc
,
Oros KKlein
et al.
. 2014.
Methods for sample acquisition and processing of serial blood and tumor biopsies for multicenter diffuse large B-cell lymphoma clinical trials.
.
Cancer Epidemiol Biomarkers Prev. 23(12):2688-93.
P
Pan H
,
Jiang Y
,
Boi M
,
Tabbò F
,
Redmond D
,
Nie K
,
Ladetto M
,
Chiappella A
,
Cerchietti L
,
Shaknovich R
et al.
. 2015.
Epigenomic evolution in diffuse large B-cell lymphomas.
.
Nat Commun. 6:6921.
« first
‹ previous
1
2
3
(current)
4
5
next ›
last »